Literature DB >> 24629348

Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq.

Zainab Khalil Mohamed Aljumaili1, Abdulghani Mohamed Alsamarai2, Wesam Suhail Najem3.   

Abstract

The human cytomegalovirus (CMV) is a major cause of congenital infections. A case-control descriptive study was conducted in Kirkuk, Iraq to determine the seroprevalence of CMV in women with bad obstetric history (BOH) compared to women with a normal previous pregnancy. The CMV IgG and IgM seroprevalence was higher in women with BOH. The CMV IgG seroprevalence was significantly influenced by pregnancy, age, residence and level of education. In addition, the current CMV infection was significantly associated with pregnancy, age, residence and education. Large families (crowding index >3) exhibited higher seroprevalence for CMV IgM (8.3%) and IgG (98.3%), but odd ratio (OR) showed no significant association between family size and seropositivity. The CMV IgG seropositivity was higher in working women (100%) compared to housewives (95.4%). However, the CMV IgM (current infection) was 6.8% in housewives and was not detected in any working women (0%). The OR exhibited no significant association between occupation and both IgM and IgG levels.
Copyright © 2014 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BOH; CMV; Cytomegalovirus; IgG; IgM; Iraq; Kirkuk; Pregnancy

Mesh:

Substances:

Year:  2014        PMID: 24629348     DOI: 10.1016/j.jiph.2013.08.006

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  3 in total

Review 1.  Breast cancer and cytomegalovirus.

Authors:  A K Richardson; L C Walker; B Cox; H Rollag; B A Robinson; H Morrin; J F Pearson; J D Potter; M Paterson; H-M Surcel; E Pukkala; M J Currie
Journal:  Clin Transl Oncol       Date:  2019-06-29       Impact factor: 3.405

2.  Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.

Authors:  Libo Zhang; Rongrong Pang; Xiang Xue; Jingjing Bao; Sheng Ye; Yudong Dai; Yishan Zheng; Qiang Fu; Zhiliang Hu; Yongxiang Yi
Journal:  Aging (Albany NY)       Date:  2020-04-22       Impact factor: 5.682

3.  Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.

Authors:  Xiaoyong Zhang; Suwen Lu; Hui Li; Yi Wang; Zhen Lu; Zhihong Liu; Qingtao Lai; Yali Ji; Xuan Huang; Yongyin Li; Jian Sun; Yingsong Wu; Xiaoning Xu; Jinlin Hou
Journal:  Virol Sin       Date:  2020-12-22       Impact factor: 4.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.